Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Bastard, Paul" or (type any "bookEditor journalEditor issueEditor" and editor="Bastard, P...

Add to list
- Journal Article
- A1
- open access
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste (UGent) , Lisa Roels (UGent) , Leslie Naesens (UGent) , Victor Bosteels (UGent) , Stijn Vanhee (UGent) , Sam Dupont (UGent) , Cedric Bosteels (UGent) , Robin Browaeys (UGent) , Niels Vandamme (UGent) , Kevin Verstaen (UGent) , et al.

(2022) JOURNAL OF EXPERIMENTAL MEDICINE. 219(2).
Add to list
Human genetic and immunological determinants of critical COVID-19 pneumonia

Qian Zhang, Paul Bastard, Adem Karbuz, Adrian Gervais, Ahmad Abou Tayoun, Alessandro Aiuti, Alexandre Belot, Alexandre Bolze, Alexandre Gaudet, Anastasiia Bondarenko, et al.

(2022) NATURE. 603(7902). p.587-598
Add to list
- Journal Article
- A1
- open access
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, et al.

(2022) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 119(21).
Add to list
- Journal Article
- A1
- open access
Distinct antibody repertoires against endemic human coronaviruses in children and adults

Taushif Khan, Mahbuba Rahman, Fatima Al Ali, Susie S. Y. Huang, Manar Ata, Qian Zhang, Paul Bastard, Zhiyong Liu, Emmanuelle Jouanguy, Vivien Beziat, et al.

(2021) JCI INSIGHT. 6(4).
Add to list
- Miscellaneous
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β

Donald C. Vinh, Laurent Abel, Paul Bastard, Matthew P. Cheng, Antonio Condino-Neto, Peter K. Gregersen, Filomeen Haerynck (UGent) , Maria-Pia Cicalese, David Hagin, Pere Soler-Palacín, et al.

(2021) JOURNAL OF CLINICAL IMMUNOLOGY. 41(7). p.1425-1442
Add to list
- Journal Article
- A1
- open access
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Takaki Asano, Bertrand Boisson, Fanny Onodi, Daniela Matuozzo, Marcela Moncada-Velez, Majistor Raj Luxman Maglorius Renkilaraj, Peng Zhang, Laurent Meertens, Alexandre Bolze, Marie Materna, et al.

(2021) SCIENCE IMMUNOLOGY. 6(62).
Add to list
- Journal Article
- A1
- open access
SARS-CoV-2–related MIS-C : a key to the viral and genetic causes of Kawasaki disease?

Vanessa Sancho-Shimizu, Petter Brodin, Aurélie Cobat, Catherine M. Biggs, Julie Toubiana, Carrie L. Lucas, Sarah E. Henrickson, Alexandre Belot, Elie Haddad, Kathie Beland, et al.

(2021) JOURNAL OF EXPERIMENTAL MEDICINE. 218(6).
Add to list
- Journal Article
- A1
- open access
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, et al.

(2021) SCIENCE IMMUNOLOGY. 6(62).
Add to list
- Journal Article
- A1
- open access
Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang, Karim Dorgham, Quentin Philippot, Jeremie Rosain, Vivien Beziat, et al.

(2020) SCIENCE. 370(6515).
Add to list
- Journal Article
- A1
- open access
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Velez, Jie Chen, Masato Ogishi, Ira K. D. Sabli, Stephanie Hodeib, Cecilia Korol, et al.

(2020) SCIENCE. 370(6515). p.422-+

Academic Bibliography

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Human genetic and immunological determinants of critical COVID-19 pneumonia

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Distinct antibody repertoires against endemic human coronaviruses in children and adults

Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

SARS-CoV-2–related MIS-C : a key to the viral and genetic causes of Kawasaki disease?

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Contents

Support

Contact